Ferring Holding SA 2023 Annual Report with Sustainability Disclosures
Company: Ferring Holding SA
Sector: Manufacturing
Country: Switzerland
Year: 2023
Type: Annual Report with Sustainability Disclosures
Pages: 81
The report highlights the 2023 launch of two first-in-class medicines, Adstiladrin and Rebyota, and the provision of one million doses of Carbetocin Ferring at an access price. It also describes sustainability progress through a double materiality assessment and strengthened ESG governance. The report presents these developments alongside Ferring's continuing focus on reproductive medicine, maternal health, gastroenterology and urology.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.